Proteocyte AI
Proteocyte Diagnostics Inc. is a molecular diagnostics company founded in 2011, focused on predicting cancer risk through advanced biomarker analysis and digital pathology. Their flagship product, STRATICYTE, enables healthcare professionals to identify oral cancer risks early, allowing for personalized treatment plans and improved patient outcomes. With a commitment to innovation, Proteocyte aims to transform cancer care and prevention, leveraging proprietary algorithms and advanced imaging techniques to provide insightful and quantifiable data for better patient management.
Proteocyte AI
Proteocyte Diagnostics Inc. is a molecular diagnostics company founded in 2011, focused on predicting cancer risk through advanced biomarker analysis and digital pathology. Their flagship product, STRATICYTE, enables healthcare professionals to identify oral cancer risks early, allowing for personalized treatment plans and improved patient outcomes. With a commitment to innovation, Proteocyte aims to transform cancer care and prevention, leveraging proprietary algorithms and advanced imaging techniques to provide insightful and quantifiable data for better patient management.